Brett King, MD, PhD - Addressing the Unmet Needs of Patients With Moderate to Severe Alopecia Areata: A Visual Exploration of Disease Pathogenesis and the Clinical Potential of Novel Therapeutic Optio

Go online to PeerView.com/WUH860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in dermatology discusses contemporary approaches to improve the care of patients with moderate to severe alopecia areata. Upon completion of this activity, participants should be better able to: Recognize the burden of disease and unmet needs experienced by patients with moderate to severe alopecia areata, Discuss the rationale for JAK inhibition as a treatment approach to alopecia areata, Compare and contrast novel JAK inhibitors for the treatment of moderate to severe alopecia areata in the context of selectivity, efficacy, and safety, Treat moderate to severe alopecia areata in accordance with current evidence and expert recommendations, identifying patients who would likely derive benefit from novel nonbiologic oral therapeutic options.